8). Analysis of approximal half-maximal doses of both compounds revealed minor effects on voltage-dependent activation only, whereas steadystate inactivation was shifted to more negative potentials by both TTX and 4,9-ah-TTX in the case of the Nav1.6 subunit, but not in the case of other TTX-sensitive ones. TTX shifted steady-state inactivation also to more negative potentials in case of the TTX-insensitive Nav1.5 subunit, where it also exerted profound effects on the time course of recovery from inactivation. Isoform-specific interaction of toxins with ion channels is frequently observed in the case of proteinaceous toxins. Although the sensitivity of Nav1.1 to 4,9-ah-TTX is not known, here we report evidence on a highly isoform-specific TTX analog that may well turn out to be an invaluable tool in research for the identification of Nav1.6-mediated function, but also for therapeutic intervention. sodium channel; tetrodotoxin TETRODOTOXIN (TTX) IS A POTENT neurotoxin that is abundant in the ovary and liver of puffer fish, but found also in other species, like, e.g., frogs, newts, and octopi (22). Since its potent and selective block of voltage-gated sodium channels was discovered (23), it has become an invaluable tool in ion channel research. It became clear that symbiotic bacteria are the origin of TTX, and subsequently several interesting metabolites of TTX biosynthesis and degradation were discovered (20). Although one of them, the rarely occurring 10-oxotetrodotoxin, turned out to be even more potent in blocking voltagedependent sodium channels than TTX itself (26), it is generally believed that TTX represents the major toxic principle of TTX action. To test for the toxicity of the abundant TTX-related compound 4,9-anhydro-TTX (4,9-ah-TTX; see Fig. 1 ), several TTX-sensitive, as well as TTX-insensitive, isoforms of voltage-dependent sodium channel ␣-subunits (Na v1.2 , Na v1.3 , Na v1.4 , Na v1.5 , Na v1.6 , Na v1.7 , and Na v1.8 ) were heterologously expressed in Xenopus laevis oocytes, and the blocking efficacy of 4,9-ah-TTX was tested and compared with TTX.
sodium channel; tetrodotoxin TETRODOTOXIN (TTX) IS A POTENT neurotoxin that is abundant in the ovary and liver of puffer fish, but found also in other species, like, e.g., frogs, newts, and octopi (22) . Since its potent and selective block of voltage-gated sodium channels was discovered (23) , it has become an invaluable tool in ion channel research. It became clear that symbiotic bacteria are the origin of TTX, and subsequently several interesting metabolites of TTX biosynthesis and degradation were discovered (20) . Although one of them, the rarely occurring 10-oxotetrodotoxin, turned out to be even more potent in blocking voltagedependent sodium channels than TTX itself (26) , it is generally believed that TTX represents the major toxic principle of TTX action. To test for the toxicity of the abundant TTX-related compound 4,9-anhydro-TTX (4,9-ah-TTX; see Fig. 1 ), several TTX-sensitive, as well as TTX-insensitive, isoforms of voltage-dependent sodium channel ␣-subunits (Na v1.2 , Na v1.3 , Na v1.4 , Na v1.5 , Na v1.6 , Na v1. 7 , and Na v1.8 ) were heterologously expressed in Xenopus laevis oocytes, and the blocking efficacy of 4,9-ah-TTX was tested and compared with TTX.
METHODS
Plasmid vectors encoding the full-length Nav1.6, Nav1.7, and Nav1.8 ␣-subunits of different mammals (rat: Nav1.2, Nav1.3, Nav1.4 and Na v1.8; human: Nav1.5 and Nav1.7; mouse: Nav1.6) were used as previously described (1, 2, 11, 16, 25, 30, 32) . Following RNA synthesis (9) and preparation of oocytes from X. laevis (12) , 0.05-0.25 ng (Na v1.2), 10 -15 ng (Nav1.3), 0.25-1.5 ng (Nav1.4), 0.25-1.5 ng (Na v1.5), 2.5 ng (Nav1.6), 25-50 ng (Nav1.7), and 50 ng (Nav1.8) RNA were injected per oocyte. Oocytes were incubated for 3-5 days at 19°C. Electrophysiological recordings on oocytes, including voltagejump protocols, drug application, and evaluation and analysis of data, were performed exactly as described recently (12) . Chemicals used were reagent grade throughout. TTX and 4,9-ah-TTX were kindly provided by ESTEVE laboratories (Barcelona, Spain). Approximal half-maximal concentrations of TTX/4,9-ah-TTX to investigate effects on channel kinetics were as follows (in nmol/l): 5/1,000 Na v1.2, 5/1,000 Na v1.3, 5/1,000 Nav1.4, 1,000/ND Nav1.5, 5/10 Nav1.6, 5/1,000 Na v1.7, 1,000/ND Nav1.8, where ND indicates not done, because of the extraorbitant amount of 4,9-ah-TTX required. Stock solutions were prepared by dissolving TTX or 4,9-ah-TTX at a concentration of 1 mmol/l in citrate Ϫ /Na ϩ buffer (10 mmol/l), pH 4.8. Small aliquots of these stock solutions were shock-frozen in liquid nitrogen and stored at Ϫ20°C until use.
RESULTS
In oocytes, expressing either of the Na v1.x ␣-subunit, sodium currents were recorded, and increasing concentrations of TTX or 4,9-ah-TTX were applied (see Fig. 2 for original recordings from the Na v1.6 and Na v1.7 subunits). As expected, TTX blocked both the Na v1.6 and the Na v1.7 subunit at nanomole per liter concentrations. Interestingly, 4,9-ah-TTX blocked the Na v1.6 isoform at nanomole per liter concentrations, quite similar to TTX. In contrast to the Na v1.6 subunit, Ͼ200 times higher concentrations of 4,9-ah-TTX were required for block of the Na v1.7 subunit and also the other TTX-sensitive isoforms tested. In contrast to the nanomole per liter concentrations of TTX used to block the TTX-sensitive isoforms, the two TTXinsensitive isoforms, Na v1.5 and Na v1.8 , required micromole per liter concentrations of TTX to be blocked. Even higher con-centrations of 4,9-ah-TTX were required to block the TTXinsensitive Na v1.5 isoform (78.5 Ϯ 11.6 mol/l). The Na v1.8 isoform did not even react to concentrations up to 100 mol/l 4,9-ah-TTX. In Fig. 3 , three characteristic dose-response relations for the peculiar behavior of Na v1. 6 (Fig. 3A) , the TTXsensitive Na v1.7 (Fig. 3B) , and the TTX-insensitive Na v1.5 ( Fig.  3C ) are shown. The complete statistical analysis of the IC 50 values for TTX and 4,9-ah-TTX is shown in Fig. 4 . With the exception of Na v1.6 , the concentrations of 4,9-ah-TTX required to achieve 50% blockage of sodium currents through a given isoform were ϳ40 to 230 times higher when compared with TTX.
Effects on channel kinetics. IC 50 concentrations, assessed for sodium channel blocking drugs during cumulative dose-response experiments, are the result of both 1) the dynamic interaction of the drug with the channel protein and its conformational equilibrium ("use dependence") and 2) the component of block that does neither depend on time nor on channel conformations ("tonic" component). To discriminate between these two components, half-maximal concentrations of TTX and 4,9-ah-TTX were applied, and their effect on channel kinetics was assessed.
Steady state activation. A typical experiment for the assessment of voltage-dependent activation and a potential influence of TTX and/or 4,9-ah-TTX on this process is shown in Fig. 5 for the Na v1.6 isoform. Although current amplitudes are reduced by both TTX and 4,9-ah-TTX (Fig. 5B) , the normalized I/E m relations are practically identical for control conditions and under the influence of TTX or 4,9-ah-TTX (Fig. 5C ). Parameters for the Na v1.x subunits tested are summarized in supplemental Table 1 (suplemental data for this article are available online at the American Journal of Physiology: Cell Physiology website.). It was observed that the potentials for half-maximal activation (Ea 0.5 ) and the slopes of the Boltzmann-isotherms (ka) were practically unchanged by both TTX and 4,9-ah-TTX for most of the Na v1.x isoforms tested. The few statistically significant changes observed were minor in their numerical value. In summary, neither TTX nor 4,9-ah-TTX exerted considerable effects on voltage-dependent steadystate activation. On the other side, ⌬G max % values were greatly and significantly reduced in all the instances tested, indicating Insets show original sodium current registrations (scaling shown with the first example applies to all). Right: same as left, but 4,9-ah-TTX was used to block sodium currents. B: same as A, but Nav1.7 was used as drug target.
that the blocking effect of both TTX and 4,9-ah-TTX was mainly the result of tonic, i.e., state-independent, action (see supplemental Table 2 , which is available as supplementary material in electronic form). Steady-state inactivation. The effect of approximately halfmaximal doses of TTX and 4,9-ah-TTX on steady-state inactivation was tested. Original current traces and h ϱ vs. E m curves for the Na v1.6 isoform are shown in Fig. 6 . Interestingly, the potential for half-maximal inactivation (Ei 0.5 ) was shifted significantly to more negative potentials by 10 nmol/l 4,9-ah-TTX (from Ϫ62.4 Ϯ 0.7 to Ϫ68.0 Ϯ 1.4 mV; P Ͻ 0,001; N ϭ 9) as well as by 5 nmol/l TTX for Na v1.6 (from Ϫ62.4 Ϯ 0.7 to Ϫ67.6 Ϯ 0.5 mV; P Ͻ 0,001; N ϭ 9; see Fig. 6C ). Such a negative shift in Ei 0.5 was observed also for the TTX-insensitive Na v1.5 subunit, in the case of TTX (from Ϫ69.0 Ϯ 1.3 to Ϫ77.5 Ϯ 0.8 mV; P Ͻ 0,001; N ϭ 9). Because of the extremely high concentrations required, 4,9-ah-TTX could not be tested on the Na v1.5 isoform. In all of the other TTXsensitive isoforms tested, such a shift in Ei 0.5 was not observed (a complete survey of results on all the isoforms tested is given in supplemental Table 3 , available as supplementary information in electronic form). To substantiate the negative shift of Ei 0.5 , induced by the toxins, on the Na v1.6 subunit, increasing concentrations of TTX were tested. It was revealed that the negative shift increased with increasing concentrations of TTX, whereas another isoform taken as a control (Na v1.7 ) remained unaffected (Fig. 6D) . Fig. 4 . Top: mean value of IC50 and the slope of dose-response curves are given as means Ϯ SE; n, no. of experiments. The mean values between TTX and 4,9-ah-TTX differ significantly at the P Ͻ 0.05 (*), 0.01 (**), and 0.001 (***) level between identical isoforms. ND, could not be determined. Bottom: IC50 values for TTX (left) or 4,9-ah-TTX (right) were tested for statistically significant differences between the different isoforms tested. The IC50 value differs significantly at the P Ͻ 0.05 (*), 0.01 (**), and 0.001 (***) level between the corresponding isoforms. NS, difference was not significant. . Cumulative dose-response curves for Nav1.6, Nav1.7, and Nav1.5. A: average cumulative dose-response curve for TTX (N ϭ 7) and 4,9-ah-TTX (N ϭ 19) on the Nav1.6 isoform. Straight and dotted lines represent least-square fit through the data. B: average cumulative dose-response curve for TTX (N ϭ 8) and 4,9-ah-TTX (N ϭ 6) on the Nav1.7 isoform. C: average cumulative dose-response curve for TTX (N ϭ 12) and 4,9-ah-TTX (N ϭ 4) on the Nav1.8 isoform.
Recovery from inactivation. In case of a use-dependent component of channel block, often the time constant of recovery from inactivation is markedly prolonged by drug/toxin action. These time constants (for both the fast and the slow inactivated state) were measured at a membrane potential of Ϫ100 mV. Original current traces for the recovery of Na v1.5 at 1 mol/l TTX and the recovery of Na v1.6 at 10 nmol/l 4,9-ah-TTX are shown in Fig. 7 . Both a direct inspection of the original traces, but also the averaged fractional recovery vs. time (Fig. 7C) , reveal that the time course of recovery from inactivation is strongly affected by TTX in the case of Na v1. 5 . Moreover, in the case of Na v1.5 , the fraction of channels exerting the slow recovery process at the cost of the fast one is also greatly enhanced by TTX. Hence, TTX exerts classical properties of a classical antiarrhythmic agent on Na v1.5 . To the contrary, neither TTX nor 4,9-ah-TTX exerted an influence on the time constants of both the fast and the slow recovery process of Na v1. 6 . Also the fraction of channels exerting fast and slow recovery was unchanged (see Fig. 7D ). In Table 1 , a summary of the results obtained on different Na v1.x isoforms with TTX and 4,9-ah-TTX is given.
DISCUSSION
Our experiments show clearly that 4,9-ah-TTX represents a highly specific blocker for the Na v1.6 isoform among the ones tested by us (Na v1.2-8 ). One important site of interaction and the site determining TTX sensitivity of Na v channels can be deduced to a single amino acid, a hydrophobic F/Y within the pore-forming region of the first pseudo-domain of TTX-sensitive Na v channels that is replaced by a polar S/C in TTXinsensitive isoforms (see, e.g., Ref. 29) . Both TTX-insensitive isoforms tested by us exerted an even lower susceptibility to 4,9-ah-TTX than to TTX. Whereas ϳ40 times higher concentrations of 4,9-ah-TTX, compared with TTX, were required to achieve half-maximal block of the Na v1.5 isoform, the Na v1.8 did not even react to 4,9-ah-TTX at the concentrations tested by us. Also, the TTX-sensitive subunits (except Na v1.6 ) required 162 (Na v1.2 ), 171 (Na v1.3 ), 220 (Na v1.4 ) and 231 (Na v1.7 ) times higher concentrations of 4,9-ah-TTX, compared with TTX, to achieve half-maximal current inhibition. Hence, 4,9-ah-TTX likely blocks sodium channels via the same site and mechanism as TTX, but generally with lower affinity. The micromole per liter amounts of 4,9-ah-TTX required to block the TTX-sensitive Na v1.x subunits tested are in good agreement with the work of Yotsu-Yamashita et al. (34) who found an equilibrium dissociation constant for the displacement of radioactively labeled saxitoxin (STX) from rat brain membranes that was ϳ100 times higher for 4,9-ah-TTX, when compared with TTX. Given the vast heterogeneity of Na v isoforms in rat brain membranes together with the fact that Na v1.6 is abundant mainly in peripheral nerves, it is not surprising that the exceptional high-affinity interaction of 4,9-ah-TTX with Na v1. 6 was not detected in this study. Apparently, the TTX receptor of Na v1.6 has unique features that makes it a high-affinity target for 4,9-ah-TTX. Because the primary determinant for TTX sensitivity, a Y in the pore region, is well conserved, other likely steric factors must be involved. Such contributions by protein surfaces, not within the actual site of drug/toxin binding but near it and within the access path for the agent, has already been described for the interaction of local anesthetics with Na v1.x subunits, when regions other than the structural determinant responsible for local anesthetic binding considerably contributed to the pharmacokinetics of drug/Na v1.x interaction (27) . Starting from the known KcsA crystal structure, Lipkind and Fozzard (18) A: scheme of voltagejump protocol: the oocyte membrane was held at Ϫ100 mV for 6 s and then stepped to the desired command potential (indicated by arrow) to elicit sodium currents. B: original current traces recorded at control conditions (left) and under the influence of 5 nmol/l TTX (bottom right) and 10 nmol/l 4,9-ah-TTX (bottom right). Command potentials were as follows: 1) Ϫ45 mV, 2) Ϫ20 mV, 3) Ϫ5 mV, and 4) ϩ20 mV. C: average Ip Na ϩ/Em relations from 9 (control; TTX) or 10 (4,9-ah-TTX) experiments, normalized to the maximal peak sodium inward current (occurring at Ϫ10 mV) Ϯ SE. Solid lines represent a fit through the data according to a Boltzmann isotherm.
pore region of the TTX-sensitive channel contributes considerably with strong nonbonded interactions between the aromatic ring of this Y (position 401 in the Na v1.4 sequence) and the nonpolar surface of TTX. Additional polar interactions between the guanidinium toxins and several amino acid residues contributing to the channel's outer vestibule are also predicted. Starting from this model and using thermodynamic mutant cycle analysis, Choudhary et al. (6) found that the C-11 hydroxyl group of TTX contributes considerably to the interaction of TTX with the outer vestibule of the Na v1.4 isoform. Moreover, their modified model predicts considerable contributions of the other hydroxyls of TTX, including those at C-9 and C-4, to the interaction of TTX with the outer vestibule. In another independent study, the unique three-dimensional properties of the outer vestibule of Na v1.6 also emerged; Schiavon et al. (28) observed that the scorpion ␤-toxin Cn2 induced a pronounced shift in voltage-dependent activation and transient resurgent currents exclusively in Na v1. 6 but not in other sodium channel isoforms. Unfortunately, because the exact threedimensional structure of the outer vestibule of sodium channels is up to now unknown, the exact structural determinants in the vestibule that account for the specific 4,9-ah-TTX blockage of Na v1.6 remain obscured. In our study, these peculiar properties of the TTX receptor of Na v1.6 are underlined by the effect of both TTX and 4,9-ah-TTX on steady-state inactivation in the case of Na v1.6 , but not in the case of the other TTX-sensitive subunits. Such a concentration-dependent shift of the potential required for half-maximal inactivation to more negative potential is frequently observed in the case of organic Na v1.x channel blockers (see ,e.g., Ref. 12), but not for TTX. Hence, TTX and 4,9-ah-TTX exert functional properties resembling local anesthetics with respect to their effect on steady-state inactivation of Na v1. 6 . Only in the TTX-insensitive Na v1.5 isoform are such pronounced effects on channel steady-state inactivation and voltage-dependent gating parameters reported (3, 5) . In the current study, we were able to show that not only steadystate inactivation of Na v1.5 is shifted to more negative potentials by TTX and 4,9-ah-TTX, but the time course of recovery from inactivation is also greatly affected by TTX: TTX significantly prolongs the time constant of the fast recovery process. In addition, the fraction of channels exerting fast recovery is substantially and significantly reduced, whereas the fraction of channels exerting slow recovery is greatly increased under the action of the toxin. Such an influence of TTX or 4,9-ah-TTX on the time constant of recovery from inactivation was not observed in the case of Na v1. 6 . Unfortunately, the complete proteomics Command potentials were as follows: 1) Ϫ100 mV, 2) Ϫ80 mV, and 3) Ϫ60 mV. C: average steady-state inactivation curve from 9 experiments Ϯ SE. Solid lines represent a fit through the data according to a Boltzmann isotherm. D: effect of increasing concentrations of TTX on half-maximal potential of steady-state inactivation of Nav1.7 (white bars; N ϭ 4) and Nav1.6 (gray bars; N ϭ 4) Ϯ SE. ***Mean values differ significantly at the P Ͻ 0.001 level from the control value. §Mean value for 10 nmol/l TTX differs significantly at the P Ͻ 0.05 level from the value at 5 nmol/l TTX. of sodium channels is, at present, unknown. An impressive body of work exists, however, that shows Na v1.6 to be an important player in several cellular functions: Na v1.6 is the major isoform in the nodes of Ranvier of myelinated nerve fibers but also abundant in unmyelinated C-fibers (8) . Its important role in cerebellar motor function is well documented (17) . Besides this, Na v1.6 has been reported to exist in Schwann cells (21) and in T tubules of the myocardium (19) , to be involved in the maturation of photoreceptors (7), and to have broad distribution in the enteric nervous system (4) and in the cochlea (14) . Na v1.6 channels have also been identified to be involved in several pathophysiological processes like chronic demyelinization accompanying multiple sclerosis (33) , diabetic neuropathy (13), epilepsia (15) , and neoplastic transformation (10) . Although isoform-specific interaction of toxins with ion channels is frequently observed with proteinaceous toxins (see, e.g., Refs. 31 and 24), such specific behavior is rarely observed for other compounds. Although the sensitivity of Na v1.1 to 4,9-ah-TTX is not known, here we report evidence on a highly isoform-specific TTX analog that may well turn out to be an invaluable tool in research for the identification of Na v1.6 -mediated function, but also for therapeutic intervention. Mean values of time constant from fast (1) and slow (2) recovery from inactivation are given Ϯ SE; N, no. of experiments. f1, Contribution of fast recovery from inactivation to the entire recovery process (Ϯ SE). *Mean value differs significantly from control at the P Ͻ 0.001 level. ND, kinetics of recovery from inactivation could not be quantified. Fig. 7 . Effect of TTX and 4,9-ah-TTX on the recovery from inactivation of Nav1.6 and Nav1.5. A: scheme of voltage-jump protocol: the oocyte membrane was held at Ϫ120 mV for 6 s to allow recovery and then steady-state inactivation was allowed for 3 s at 0 mV. Subsequently, recovery at Ϫ100 mV took place for various time intervals, and available sodium currents were elicited. B: original current traces recorded from Nav1.5 at control conditions (top left) and at 1 mol/l TTX (top right). Recovery time intervals were as follows: 1) 50 s, 2) 5 s, 3) 500 ms, and 4) 5 ms. Recordings obtained from Nav1.6 at control conditions (bottom left) and at 10 nmol/l 4,9-ah-TTX (bottom right) are also displayed. Recovery time intervals were as follows: 1) 50 s, 2) 5 s, 3) 500 ms, and 4) 5 ms. C: average fractional recovery of Nav1.5 at control (white circles; N ϭ 7) and at 1 mol/l TTX (black circles; N ϭ 6) Ϯ SE. Solid lines represent a fit through the data according to a biexponential function. D: average fractional recovery of Nav1.6 at control (white circles; N ϭ 9), at 5 nmol/l TTX (black circles; N ϭ 10), and at 10 nmol/l 4,9-ah-TTX (gray circles; N ϭ 11) Ϯ SE. Solid lines represent a fit through the data according to a biexponential function.
